Skip to main content
main-content
Erschienen in: Journal of Cutaneous Medicine and Surgery 3/2003

01.07.2003 | Case Report

Facial Lipoatrophy Following Systemic Lupus Erythematosus

verfasst von: Audrey Dupéré, Yves Poulin

Erschienen in: Journal of Cutaneous Medicine and Surgery | Ausgabe 3/2003

Einloggen, um Zugang zu erhalten

Abstract

Background: Acquired partial lipodystrophy is a rare disorder. An association with systemic lupus erythematosus has been reported. In these cases, an immunologic basis is suggested by the presence of C3 nephritic factor and hypocomplementemia. Objective: The following report presents the case of a woman who developed a rapid loss of facial subcutaneous fat a few months after complete spontaneous resolution of cutaneous lesions of lupus. Conclusion: Absence of C3NeF in this case suggests that other immunological factors may be involved in the pathogenesis.
Literatur
1.
Zurück zum Zitat Black, MM, Cunliffe, WJ 1998Lipodystrophy.Rook, AWilkinson, DSEbling, FJG eds. Textbook of Dermatology, 6th edBlackwell ScienceOxford24262431 Black, MM, Cunliffe, WJ 1998Lipodystrophy.Rook, AWilkinson, DSEbling, FJG eds. Textbook of Dermatology, 6th edBlackwell ScienceOxford24262431
2.
Zurück zum Zitat Garg, A 2000Lipodystrophies.Am J Med108143152 Garg, A 2000Lipodystrophies.Am J Med108143152
3.
Zurück zum Zitat Font, J, Herrero, C, Bosch, X,  et al. 1990Systemic lupus erythemetosus in a patient with lipodystrophy.J Am Acad Dermatol22337340 PubMed Font, J, Herrero, C, Bosch, X,  et al. 1990Systemic lupus erythemetosus in a patient with lipodystrophy.J Am Acad Dermatol22337340 PubMed
4.
Zurück zum Zitat Simpson, NB, Cunliffe, WJ, Davison, AM 1979Partial lipodystrophy, glomerulonephritis and hypocomplementaemia.Br J Dermatol1011112 Simpson, NB, Cunliffe, WJ, Davison, AM 1979Partial lipodystrophy, glomerulonephritis and hypocomplementaemia.Br J Dermatol1011112
5.
Zurück zum Zitat Jasin, HE 1979Systemic lupus erythematosus, partial lipodystrophy and hypocomplementemia.J Rheumatol64350 PubMed Jasin, HE 1979Systemic lupus erythematosus, partial lipodystrophy and hypocomplementemia.J Rheumatol64350 PubMed
6.
Zurück zum Zitat Walport, MJ, Davies, KA, Botto, M,  et al. 1994C3 nephritic factor and SLE: report of four cases and review of the literature.Q J Med87609615 Walport, MJ, Davies, KA, Botto, M,  et al. 1994C3 nephritic factor and SLE: report of four cases and review of the literature.Q J Med87609615
7.
Zurück zum Zitat Cronin, CC, Higgins, T, Molloy, M 1995Lupus, C3 nephritic factor and partial lipodystrophy.Q J Med88298299 Cronin, CC, Higgins, T, Molloy, M 1995Lupus, C3 nephritic factor and partial lipodystrophy.Q J Med88298299
8.
Zurück zum Zitat Chartier, S, Buzzanga, JB, Paquin, F 1987Partial lipodystrophy associated with a type 3 form of membranoproliferative glomerulonephritis.J Am Acad Dermatol16201205 PubMed Chartier, S, Buzzanga, JB, Paquin, F 1987Partial lipodystrophy associated with a type 3 form of membranoproliferative glomerulonephritis.J Am Acad Dermatol16201205 PubMed
9.
Zurück zum Zitat Gürbüz, O, Yücelten, D, Ergun, T,  et al. 1995Partial lipodystrophy.Int J Dermatol343637 PubMed Gürbüz, O, Yücelten, D, Ergun, T,  et al. 1995Partial lipodystrophy.Int J Dermatol343637 PubMed
10.
Zurück zum Zitat Daha, MR, Fearon, DT, Austen, KF 1976C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.J Immunol11617 PubMed Daha, MR, Fearon, DT, Austen, KF 1976C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.J Immunol11617 PubMed
11.
Zurück zum Zitat Wayte, J, Bird, G, Wilkinson, JD 1996The clinical significance of partial lipoatrophy and C3 hypocomplementaemia: a report of two cases.Clin Exp Dermatol21131134 CrossRefPubMed Wayte, J, Bird, G, Wilkinson, JD 1996The clinical significance of partial lipoatrophy and C3 hypocomplementaemia: a report of two cases.Clin Exp Dermatol21131134 CrossRefPubMed
12.
Zurück zum Zitat Porter, WM, O’Gorman–Lalor, O, Lane, RJM,  et al. 2000Barraquer–Simons lipodystrophy, Raynaud’s phenomenom and cutaneous vasculitis.Clin Exp Dermatol25277280 CrossRefPubMed Porter, WM, O’Gorman–Lalor, O, Lane, RJM,  et al. 2000Barraquer–Simons lipodystrophy, Raynaud’s phenomenom and cutaneous vasculitis.Clin Exp Dermatol25277280 CrossRefPubMed
13.
Zurück zum Zitat Commens, C, O’Neill, P, Walker, G 1990Dermatomyositis associated with multifocal lipoatrophy.J Am Acad Dermatol22966969 PubMed Commens, C, O’Neill, P, Walker, G 1990Dermatomyositis associated with multifocal lipoatrophy.J Am Acad Dermatol22966969 PubMed
14.
Zurück zum Zitat Torrelo, A, Espana, A, Boixeda, P,  et al. 1991Partial lipodystrophy and dermatomyositis.Arch Dermatol12718461847 CrossRefPubMed Torrelo, A, Espana, A, Boixeda, P,  et al. 1991Partial lipodystrophy and dermatomyositis.Arch Dermatol12718461847 CrossRefPubMed
15.
Zurück zum Zitat Kavanagh, GM, Colaco, B, Kennedy, CTC 1993Juvenile dermatomyositis associated with partial lipoatrophy.J Am Acad Dermatol28348351 PubMed Kavanagh, GM, Colaco, B, Kennedy, CTC 1993Juvenile dermatomyositis associated with partial lipoatrophy.J Am Acad Dermatol28348351 PubMed
16.
Zurück zum Zitat Huemer, C, Kitson, H, Malleson, PN,  et al. 2001Lipodystrophy in patients with juvenile dermatomyositis–evaluation of clinical and metabolic abnormalities.J Rheumatol28610615 PubMed Huemer, C, Kitson, H, Malleson, PN,  et al. 2001Lipodystrophy in patients with juvenile dermatomyositis–evaluation of clinical and metabolic abnormalities.J Rheumatol28610615 PubMed
17.
Zurück zum Zitat Pujol, RM, Domingo, P, Guiu, XM,  et al. 2000HIV-1 protease inhibitor-associated partial lipodystrophy: clinicopathologic review of 14 cases.J Am Acad Dermatol42193198 PubMed Pujol, RM, Domingo, P, Guiu, XM,  et al. 2000HIV-1 protease inhibitor-associated partial lipodystrophy: clinicopathologic review of 14 cases.J Am Acad Dermatol42193198 PubMed
18.
Zurück zum Zitat Perrot, H 1988Les lipoatrophies localisées.Ann Dermatol Venereol115523527 PubMed Perrot, H 1988Les lipoatrophies localisées.Ann Dermatol Venereol115523527 PubMed
19.
Zurück zum Zitat Tan, EM, Cohen, AS, Fries, JF,  et al. 1982The 1982 revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum2512711277 PubMed Tan, EM, Cohen, AS, Fries, JF,  et al. 1982The 1982 revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum2512711277 PubMed
20.
Zurück zum Zitat Mathieson, PW, Wurzner, R, Oliveira, DBG,  et al. 1993Complement-mediated adipocyte lysis by nephritic factor sera.J Exp Med17718271831 PubMed Mathieson, PW, Wurzner, R, Oliveira, DBG,  et al. 1993Complement-mediated adipocyte lysis by nephritic factor sera.J Exp Med17718271831 PubMed
21.
Zurück zum Zitat Ledru, E, Christeff, N, Patey, O,  et al. 2000Alteration of tumor necrosis factor-alpha T-cell homeostasis following potent antiretroviral therapy: contribution to the development of human immunodeficiency virus-associated lipodystrophy syndrome.Blood9531913198 PubMed Ledru, E, Christeff, N, Patey, O,  et al. 2000Alteration of tumor necrosis factor-alpha T-cell homeostasis following potent antiretroviral therapy: contribution to the development of human immunodeficiency virus-associated lipodystrophy syndrome.Blood9531913198 PubMed
22.
Zurück zum Zitat Mynarcik, DC, McNurlan, MA, Steigbigel, RT,  et al. 2000Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy.J Acquir Immune Defic Syndr25312321 CrossRefPubMed Mynarcik, DC, McNurlan, MA, Steigbigel, RT,  et al. 2000Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy.J Acquir Immune Defic Syndr25312321 CrossRefPubMed
23.
Zurück zum Zitat Pachman, LM, Liotta–Davis, MR, Hong, DK,  et al. 2000TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications.Arthritis Rheum4323682377 CrossRefPubMed Pachman, LM, Liotta–Davis, MR, Hong, DK,  et al. 2000TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications.Arthritis Rheum4323682377 CrossRefPubMed
24.
Zurück zum Zitat Ducours, JL, Poizac, P, Ardanza, B,  et al. 1991Barraquer–Simons syndrome and facial lipo-filling. A propos of a case.Rev Stomatol Chir Maxiliofac92105111 Ducours, JL, Poizac, P, Ardanza, B,  et al. 1991Barraquer–Simons syndrome and facial lipo-filling. A propos of a case.Rev Stomatol Chir Maxiliofac92105111
25.
26.
Zurück zum Zitat Oral, EA, Simha, V, Ruiz, E,  et al. 2002Leptin-replacement therapy for lipodystrophy.N EngI J Med346570578 CrossRef Oral, EA, Simha, V, Ruiz, E,  et al. 2002Leptin-replacement therapy for lipodystrophy.N EngI J Med346570578 CrossRef
Metadaten
Titel
Facial Lipoatrophy Following Systemic Lupus Erythematosus
verfasst von
Audrey Dupéré
Yves Poulin
Publikationsdatum
01.07.2003
Erschienen in
Journal of Cutaneous Medicine and Surgery / Ausgabe 3/2003
Print ISSN: 1203-4754
Elektronische ISSN: 1615-7109
DOI
https://doi.org/10.1007/s10227-002-0159-5

Weitere Artikel der Ausgabe 3/2003

Journal of Cutaneous Medicine and Surgery 3/2003 Zur Ausgabe

The World Literature

2. Internal Medicine

The World Literature

10. Inflammatory

Neu im Fachgebiet Dermatologie

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Dermatologie und bleiben Sie gut informiert – ganz bequem per eMail.